This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Food and Drug Administration has approved this technology for the treatment of essential tremor and Parkinson's disease, and its indications are expanding to include various intracranial diseases. High-intensity FUS is a safe and effective treatment for various intracranial diseases.
Is there a signature biomarker for younger/early-onset Alzheimer’s Disease (EOAD)? Sporadic early-onset Alzheimer’s disease (EOAD) is rare and understudied. The Sporadic Early-onset Alzheimer’s Disease Signature Of Atrophy: Preliminary Findings From The Longitudinal Early-onset Alzheimer’s Disease Study (LEADS) Cohort.
milla1cf Fri, 11/03/2023 - 12:22 November 3, 2023 — Guerbet , a global leader in medical imaging with more than 30 years of experience in MRI, announced today its schedule of activities at the 2023 Radiological Society of North America (RSNA) Scientific Assembly and Annual Meeting from November 26-30 in Chicago, IL.
milla1cf Wed, 12/20/2023 - 15:41 December 20, 2023 — Terran Biosciences, Inc. , While neuromelanin was first described in the 19 th century, researchers have elucidated its possible role as a biomarker for neurological disorders such as Parkinson’s disease in the last two decades. For more information: www.nm-101.com
milla1cf Fri, 06/02/2023 - 20:28 June 2, 2023 — Philips has entered into a collaboration with medical imaging company Polarean to advance the field of hyperpolarized Xenon MRI for patients with respiratory illness. Friday, June 2, 2023 - 20:28
christine.book Tue, 06/20/2023 - 14:03 June 20, 2023 — Ascelia Pharma presented data from its Orviglance Hepatic Impairment study during the European Society of Gastrointestinal and Abdominal Radiology (ESGAR) 2023 annual meeting held June 14-16 in Valencia, Spain.
milla1cf Fri, 10/20/2023 - 18:29 October 20, 2023 — In certain cases, a new method can provide as much information from brain images taken with computed tomography (CT) as images captured with magneticresonanceimaging (MRI). For more information: [link] Friday, October 20, 2023 - 18:29
milla1cf Mon, 12/11/2023 - 14:23 December 11, 2023 — Bracco Imaging S.p.A. , 1,2 "The final approval of gadopiclenol by the European Commission marks a significant milestone in the field of diagnostic imaging. 5 Gadolinium is a rare earth metal that has unique magnetic properties that make it useful for MRI imaging.
milla1cf Thu, 07/06/2023 - 22:19 July 7, 2023 — Bayer , a global leader in radiology, has initiated the Phase III clinical development program called QUANTI , aiming to evaluate the safety and efficacy of gadoquatrane, an investigational extracellular macrocyclic gadolinium-based contrast agent (GBCA) for use in magneticresonanceimaging ( MRI ).
Furthermore, this partnership perfectly aligns with our objective of extending the reach of XENOVIEW MRI, to provide tools to physicians that treat patients suffering from chronic lung disease.” XENOVIEW has not been evaluated for use with lung perfusion imaging. Susan Wood , Ph.D.,
milla1cf Fri, 12/01/2023 - 12:59 December 1, 2023 — In today's healthcare environment, the industry faces various pressing challenges. The magneticresonance (MR) field is experiencing growing demands for precise imaging and diagnosis, increased productivity, all amid a global shortage of radiologists and patient backlogs.
The world of medical imaging is marking a significant milestone in 2023: the 50th anniversary of magneticresonanceimaging (MRI). It assists in identifying diseases related to spine lesions, tumors, and stroke impacting the area of blood vessels and brain.
milla1cf Wed, 06/07/2023 - 19:51 June 6, 2023 — GE HealthCare announced the FDA clearance and launch of Sonic DL – a state-of-the-art deep learning-based technology designed to dramatically accelerate image acquisition in magneticresonanceimaging ( MRI ).
milla1cf Mon, 06/26/2023 - 19:53 June 27, 2023 — Bayer announced that Ultravist (iopromide)-300, -370, its iodine-based contrast agent, has been approved by the U.S. Updated April 4, 2023. Retrieved June 12, 2023 from: [link]. Retrieved May 26, 2023 from: [link]. for use in CEM. Sensakovic, et al.
A 55-year-old woman with a history of end-stage kidney disease on peritoneal dialysis presents due to abdominal pain. Barium contrast X-ray CT scan Magneticresonanceimaging Ultrasound FOR THE RIGHT ANSWER CLICK ON THE ROSH REVIEW LOGO BELOW References Burkart JM, Bleyer A. Accessed September 28, 2023.
milla1cf Mon, 05/08/2023 - 15:40 May 8, 2023 — Artificial intelligence and machine learning (AI/ML) technologies are constantly finding new applications across several disciplines. Medicine is no exception, with AI/ML being used for the diagnosis, prognosis, risk assessment, and treatment response assessment of various diseases.
The results also follow those of the PICTURE clinical trial published in Investigative Radiology in May, 2023, which found the non-inferior quality of morphologic assessment of lesions of the brain and spine with VUEWAY compared with Gadavist. mmol/kg gadopiclenol (VUEWAY) with 0.1 mmol/kg versus a full dose of gadobutrol (0.1 mmol/kg). [ii],
Eva van Rikxoort, the founder and CEO of Thirona, emphasizes the role of solutions like LungQ in ushering in a new era of personalized and less invasive procedures for lung diseases. 3 Tesla (3T) magneticresonanceimaging whole-body scanner. Strongest-Ever Gradient System: Siemens Magnetom Cima.X The Magnetom Cima.X
Key Points: While magneticresonanceimaging (MRI) adequately detects the size and presence of osteophytes (OPs) in the medial tibio-femoral compartment, it underestimates OPs in all other knee compartments of osteoarthritic patients. In the research setting, weight bearing CT (WBCT) imaging could be a useful tool.
Along with the new Revolution RT unveiling, GE HealthCare is also revealing an updated and artificial intelligence (AI)-enhanced version of its Intelligent Radiation Therapy (iRT) platform, which interfaces with the Spectronic magneticresonanceimaging (MRI) Planner. Last accessed February 2023. Available at: [link] .
tesla MRI AI body composition analysis Cardiac PET Cryo/thermoablation CT colonography Genicular artery embolization Hyperpolarized xenon-129 MRI PET/MRI Photon-counting CT Radiomics Theranostics Whole-body MRI screening Image of the Year 3D PET/MR image. Image from Shilpa Vijayakumar, MD, of Brigham and Women’s Hospital, et al.
milla1cf Tue, 08/08/2023 - 20:34 August 8, 2023 — Fresenius Kabi announced it has launched Gadobutrol Injection, a generic substitute for the contrast agent Gadavist, which is used in magneticresonanceimaging (MRI) procedures. To assess the presence and extent of malignant breast disease in adult patients.
milla1cf Tue, 10/03/2023 - 12:04 October 3, 2023 — The University of Texas MD Anderson Cancer Center’s Research Highlights showcases the latest breakthroughs in cancer care, research and prevention. This study provides a possible link between metastasis-direction radiation, the systemic immune response and overall disease control.
Magneticresonanceimaging ( MRI ) plays an increasingly important role in the early diagnosis of prostate cancer. We will continue to invest in advanced technology solutions to fight this disease, collaborate with healthcare professionals to further improve our technology and accessibility. Huisman (NL), J. Rusu (USA).
Diagnosis and Management of Cerebral Small Vessel Disease. 0000000000001232 Cerebral small vessel disease (CSVD) is one of the most common clinical conditions that a neuroimager will encounter. Anti-amyloid antibody therapies in Alzheimer’s disease. Sharrief A. Continuum (Minneap Minn). 2023;29(2):501-518. doi:10.1212/CON.0000000000001232
We organize all of the trending information in your field so you don't have to. Join 5,000 users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content